Search

Cross-section of engineered heart tissue derived from iPSCs stained for troponin (green) and nuclei (blue). Cells formed an aligned structure, mimicking the architecture of human myocardium.

ANSIR Lab news

Skip to main content Depression Research Our Clinical Trials Depression is a major health challenge affecting more than 300 million people globally. Research suggests that 1 in 6 people will experience depression in their lifetime with an 18% increase over the past decade. Of the more than 17 million individuals diagnosed with depression living in the United States, more than 5 million experience treatment-resistant depression. Many of our trials focus on those individuals struggling with

Join the Pan Lab

Skip to main content Resilience and Suicidal Ideation Research Because depression often begins early in life, our goal is to proactively study the disease in young people to ultimately prevent or minimize its impact population-wide. To further this goal of reducing adolescent suicidality, our team has received two grants from the American Foundation for Suicide Prevention (AFSP) and the National Institute of Mental Health (NIMH). RAD Resilience Against Depression Study A longitudinal

The Mosley Lab develops and applies innovative genomic and informatics approaches to identify opportunities to use genetic background to inform clinical and public health decision-making, to identify risk factors and biomarkers of disease, and to identify and reduce heath inequities in vulnerable

Mendell Lab photo gallery

Skip to main content Our Research Social Disconnectedness and Cognitive Health in Aging Our work examines how loneliness and social isolation impact brain health among older adults. Dr. Yu has developed and tested behavioral interventions, ranging from group-based programs to one-on-one conversational support, that foster meaningful connection and cognitive engagement. Her work demonstrates that increasing social interaction can help slow cognitive decline and improve quality of life in aging

Skip to main content Net Benefit of HCC screening We have promoted the concept of net benefit for HCC screening, which involves balancing early detection with potential screening-related harms. We have characterized the clinical benefits of screening, including improved early tumor detection and associations with improved survival. Our group conducted the first studies to prospectively measure physical, financial, and psychological harms of screening. Choi DT, Kum H, Park S, Ohsfeldt RL, Parikh

Oz Lab's research on Fat Imaging